secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2026-08-13T11:30:31+00:00
Accession:  0001104659-26-095464
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium enters $50M accelerated share repurchase with Jefferies
-----------------------------------------------------------------

- ASR agreement with Jefferies LLC to repurchase $50M of common stock, announced Aug 12, 2026.
- Initial delivery of 1,556,420 shares at $25.70 closing price (Aug 12, 2026), ~80% of expected total.
- Part of $150M buyback program authorized July 2025; final settlement expected by Q4 2026.
- Final share count based on VWAP during term; ~32.5M shares outstanding as of June 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465926095464/0001104659-26-095464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465926095464/tm2623090d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-095464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer